Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's β-amyloid proteins

Journal of Neuroscience Research

Volumn 84, Issue 2, 2006, Pages 427-433

  Fujiwara, Hironori ^a   Iwasaki, Koh ^a   Furukawa, Katsutoshi ^a   Seki, Takashi ^a   He, Mei ^a   Maruyama, Masahiro ^a   Tomita, Naoki ^a   Kudo, Yukitsuka ^b   Higuchi, Makoto ^c   Saido, Takaomi C ^c   Maeda, Sumihiro ^c   Takashima, Akihiko ^c   Hara, Masahiko ^d   Ohizumi, Yasushi ^b   Arai, Hiroyuki ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^d Japan Science and Technology Agency   (Japan)

Author keywords

amyloid; Alzheimer's disease; Medicinal herb; Thioflavin T; Uncaria rhynchophylla

Indexed keywords

ALKALOID; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CINNAMOMUM CASSIA EXTRACT; HERBACEOUS AGENT; INDOLE; OXINDOLE; PAEONIA SUFFRUTICOSA EXTRACT; PLANT EXTRACT; THIOFLAVINE; UNCARIA RHYNCHOPHYLLA EXTRACT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; ATOMIC FORCE MICROSCOPY; CHINESE MEDICINE; CINNAMOMUM CASSIA; DOSE RESPONSE; DRUG ACTIVITY; DRUG INHIBITION; DRUG ISOLATION; ELECTROPHORESIS; FIBER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NEUROPROTECTION; PAEONIA SUFFRUTICOSA; PRIORITY JOURNAL; UNCARIA; UNCARIA RHYNCHOPHYLLA;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FLUORESCENT DYES; MICROSCOPY, ATOMIC FORCE; THIAZOLES; UNCARIA;

EID: 33746435758     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20891     Document Type: Article

References (28)

1. Anderton BH, Callahan L, Coleman P, Davies P, Flood D, Jicha GA, Ohm T, Weaver C. 1998. Dendritic changes in Alzheimer's disease and factors that may underlie these changes. Prog Neurobiol 55:595-609.
2. Barrow CJ, Zagorski MG. 1991. Solution structures of β-peptide and its constituent fragments: relation to amyloid deposition. Science 253:179-182.
3. Darreh-Shori T, Hellstrom-Lindahl E, Flores-Flores C, Guan ZZ, Soreq H, Nordberg A. 2004. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients. J Neurochem 88:1102-1113.
4. Dohi K, Satoh K, Ikeda Y, Ohtaki H, Shioda S, Aruga T. 2003. Neuroprotective effect from ischemia and direct free radical scavenging activity of Choto-san (kampo medicine). Acta Neurochir Suppl 86:123-127.
5. Iwasaki K, Kobayashi S, Chimura Y, Taguchi M, Inoue K, Cho S, Akiba T, Arai H, Cyong JC, Sasaki H. 2004. A randomized, double-blind, placebo-controlled clinical trial of the Chinese medicinal herb "ba wei di huang wan" in the treatment of dementia. J Am Geriatr Soc 52:1518-1521.
6. Iwasaki K, Satoh-Nakagawa T, Maruyama M, Monma Y, Nemoto M, Tomita N, Tanji H, Fujiwara H, Seki T, Fujii M, Arai H, Sasaki H. 2005. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry 66:248-252.
7. Kang TH, Murakami Y, Takayama H, Kitajima M, Aimi N, Watanabe H, Matsumoto K. 2004. Protective effect of rhynchophylline and isorhynchophylline on in vitro ischemia-induced neuronal damage in the hippocampus: putative neurotransmitter receptors involved in their action. Life Sci 76:331-343.
8. Kirkitadze MD, Bitan G, Teplow DB. 2002. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J Neurosci Res 69:567-577.
9. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. 1997. A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia. North American EGb Study Group. JAMA 278:1327-1332.
10. Legleiter J, Czilli DL, Gitter B, DeMattos RB, Holtzman DM, Kowalewski T. 2004. Effect of different anti-Abeta antibodies on Aβ fibrillogenesis as assessed by atomic force microscopy. J Mol Biol 335:997-1006.
11. Li QX, Maynard C, Cappai R, McLean CA, Cherny RA, Lynch T, Culvenor JG, Trevaskis J, Tanner JE, Bailey KA, Czech C, Bush AI, Beyreuther K, Masters CL. 1999. Intracellular accumulation of detergent-soluble amyloidogenic Aβ fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice. J Neurochem 72:2479-2487.
12. Mahakunakorn P, Tohda M, Murakami Y, Matsumoto K, Watanabe H. 2004. Antioxidant and free radical-scavenging activity of Choto-san and its related constituents. Biol Pharm Bull 27:38-46.
13. Mahakunakorn P, Tohda M, Murakami Y, Watanabe H, Matsumoto K. 2005. Effects of Choto-san and its related constituents on endogenous antioxidant systems. Biol Pharm Bull 28:53-57.
14. Millard CB, Broomfield CA 1995. Anticholinesterases: medical applications of neurochemical principles. J Neurochem 64:1909-1918.
15. Multhaup G. 1997. Amyloid precursor protein, copper and Alzheimer's disease. Biomed Pharmacother 51:105-111.
16. Nakagawasai O, Yamadera F, Iwasaki K, Arai H, Taniguchi R, Tan-No K, Sasaki H, Tadano T. 2004. Effect of kami-untan-to on the impairment of learning and memory induced by thiamine-deficient feeding in mice. Neuroscience 125:233-241.
17. Ono K, Hasegawa K, Naiki H, Yamada M. 2004. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res 75:742-750.
18. Park CH, Lee YJ, Lee SH, Choi SH, Kim HS, Jeong SJ, Kim SS, Suh YH. 2000. Dehydroevodiamine.HCl prevents impairment of learning and memory and neuronal loss in rat models of cognitive disturbance. J Neurochem 74:244-253.
19. Selkoe DJ. 2002. Alzheimer's disease is a synaptic failure. Science 298:789-791.
20. Shi JS, Kenneth HG. 2002. Effect of rhynchophylline on apoptosis induced by dopamine in NT2 cells. Acta Pharmacol Sin 23:445-449.
21. Shimada Y, Goto H, Itoh T, Sakakibara I, Kubo M, Sasaki H, Terasawa K. 1999. Evaluation of the protective effects of alkaloids isolated from the hooks and stems of Uncaria rhynchophylla on glutamate-induced neuronal death in cultured cerebellar granule cells from rats. J Pharm Pharmacol 51:715-722.
22. Suemoto T, Okamura N, Shiomitsu T, Suzuki M, Shimadzu H, Akatsu H, Yamamoto T, Kudo Y, Sawada T. 2004. In vivo labeling of amyloid with BF-108. Neurosci Res 48:65-74.
23. Suzuki T, Arai H, Iwasaki K, Tanjj H, Higuchi M, Okamura N, Matsui T, Maruyama M, Yabe T, Toriizuka K, Yamada H, Hanawa T, Ikarashi Y, Sasaki H. 2001. A Japanese herbal medicine (Kami-Untan-To) in the treatment of Alzheimer's disease: a pilot study. Alzheimer Rep 4:177-182.
24. Terasawa K, Shimada Y, Kita T, Yamamoto T, Tosa H, Tanaka N, Saito Y, Kanaki E, Goto S, Mizushima N, Fujioka M, Takase S, Seki H, Kimura I, Ogawa T, Nakamura S, Araki G, Maruyama I, Maruyama Y, Takaori S. 1997. Choto-san in the treatment of vascular dementia: a double-blind, placebo-controlled study. Phytomedicine 4:15-22.
25. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P. 1988. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 38:359-346.
26. Wirths O, Multhaup G, Bayer TA. 2004. A modified β-amyloid hypothesis: intraneuronal accumulation of the β-amyloid peptide-the first step of a fatal cascade. J Neurochem 91:513-520.
27. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM. 2005. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280:5892-5901.
28. Yokoyama K, Shimada Y, Hori E, Sekiya N, Goto H, Sakakibara I, Nishijo H, Terasawa K. 2004. Protective effects of Choto-san and hooks and stems of Uncaria rhynchophylla against delayed neuronal death after transient forebrain ischemia in gerbil. Phytomedicine 11:478-489.